New Key Statistics Module, Z-Score and F-Score
TSX:CSCI Key Ratios
Market Cap C$ M | 16.05 |
Enterprise Value C$ M | -19.62 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.44 |
Price/Sales | 0.96 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 10.00 |
EPS (TTM) C$ | -3.46 |
Beneish M-Score | -1.97 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -698.30 |
EV-to-EBIT | 2.19 |
EV-to-EBITDA | 2.82 |
PEG | -- |
Shares Outstanding M | 3.12 |
Net Margin (%) | -67.87 |
Operating Margin % | -114.54 |
Pre-tax Margin (%) | -87.03 |
Quick Ratio | 3.05 |
Current Ratio | 3.36 |
ROA % (ttm) | -17.90 |
ROE % (ttm) | -23.49 |
ROIC % (ttm) | -39.52 |
Dividend Yield % | -- |
Altman Z-Score | 0.62 |
TSX:CSCI Number of Guru Trades
TSX:CSCI Volume of Guru Trades
Gurus Latest Trades with TSX:CSCI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:CSCI is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cosciens Biopharma Inc Insider Transactions
No Available Data